BR9711681A - New m-all - Google Patents

New m-all

Info

Publication number
BR9711681A
BR9711681A BR9711681A BR9711681A BR9711681A BR 9711681 A BR9711681 A BR 9711681A BR 9711681 A BR9711681 A BR 9711681A BR 9711681 A BR9711681 A BR 9711681A BR 9711681 A BR9711681 A BR 9711681A
Authority
BR
Brazil
Prior art keywords
new
Prior art date
Application number
BR9711681A
Other languages
Portuguese (pt)
Inventor
Jeremy N Bradbeer
Jacqueline Beesley
Richard Brasdbeer
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR9711681A publication Critical patent/BR9711681A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9711681A 1996-09-06 1997-09-03 New m-all BR9711681A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24
PCT/US1997/015475 WO1998009619A1 (en) 1996-09-06 1997-09-03 Novel methods

Publications (1)

Publication Number Publication Date
BR9711681A true BR9711681A (en) 1999-08-24

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9711681A BR9711681A (en) 1996-09-06 1997-09-03 New m-all
BR9711676A BR9711676A (en) 1996-09-06 1997-09-03 Post-menopausal disease-asd treatment method including osteoporosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR9711676A BR9711676A (en) 1996-09-06 1997-09-03 Post-menopausal disease-asd treatment method including osteoporosis

Country Status (16)

Country Link
EP (2) EP0927029A4 (en)
JP (2) JP2002515046A (en)
KR (2) KR20000068472A (en)
CN (2) CN1236313A (en)
AR (1) AR008155A1 (en)
AU (2) AU4409797A (en)
BR (2) BR9711681A (en)
CA (2) CA2264943A1 (en)
CO (2) CO4920218A1 (en)
CZ (1) CZ76699A3 (en)
IL (1) IL128645A0 (en)
NO (2) NO991096L (en)
PL (2) PL332278A1 (en)
TR (2) TR199900506T2 (en)
TW (1) TW411273B (en)
WO (2) WO1998009519A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5749998A (en) * 1997-02-11 1998-08-26 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (en) * 1999-02-12 2000-08-17 Stefan Neubauer Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
DE69316633T2 (en) * 1992-09-15 1998-05-20 Merrell Dow Pharmaceuticals Inc., Cincinnati, Ohio NON-METABOLIZABLE CLOMIPHENE ANALOGS FOR THE TREATMENT OF TAMOXIFEN-RESISTANT TUMORS
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
AU6277396A (en) * 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
EP0929216A4 (en) 2001-04-04
CO4920218A1 (en) 2000-05-29
AU4409797A (en) 1998-03-26
EP0927029A4 (en) 2001-06-13
CN1236313A (en) 1999-11-24
NO991096D0 (en) 1999-03-05
PL332278A1 (en) 1999-08-30
WO1998009619A1 (en) 1998-03-12
CO5070658A1 (en) 2001-08-28
JP2002515047A (en) 2002-05-21
TR199900506T2 (en) 1999-07-21
WO1998009519A1 (en) 1998-03-12
KR20000068472A (en) 2000-11-25
AU4247397A (en) 1998-03-26
NO991097D0 (en) 1999-03-05
AR008155A1 (en) 1999-12-09
CA2264943A1 (en) 1998-03-12
BR9711676A (en) 1999-08-24
CZ76699A3 (en) 1999-08-11
KR20000068473A (en) 2000-11-25
EP0927029A1 (en) 1999-07-07
EP0929216A1 (en) 1999-07-21
TW411273B (en) 2000-11-11
CN1236299A (en) 1999-11-24
IL128645A0 (en) 2000-01-31
CA2264775A1 (en) 1998-03-12
TR199900504T2 (en) 1999-06-21
NO991096L (en) 1999-03-05
JP2002515046A (en) 2002-05-21
NO991097L (en) 1999-03-05
PL332038A1 (en) 1999-08-16

Similar Documents

Publication Publication Date Title
BR9703884A (en) Cycloalkanopyridines
ATE208395T1 (en) THIOPHENOPYRIMIDINES
BR9704464A (en) Eviscerator
DE69731470D1 (en) SPIRAL-scrambling
ATE262512T1 (en) ARYLALKANOYLPYRIDAZINE
ATE208773T1 (en) QUINOXALINDIONE
DE59609702D1 (en) powder-spraying
ATE353652T1 (en) ESTROPROGESTATIVE CONTRACEPTIONAL
BR9703563A (en) Hydromancal
BR9703835A (en) Hydromancal
BR9707467A (en) 1-Pyrazol-3-ylethyl-4-indole-3-ylpiperdins
NO991144L (en) LÕsanordning
BR9711681A (en) New m-all
BR9708716A (en) 3-cyanoaryl-pyrazoles
FI963575A0 (en) Sitskonstruktion
FI962504A0 (en) Hjaelm Foer cycklister
ATE267568T1 (en) EPITHESIS
DE59610630D1 (en) Paradontalsonde
BR7601310U (en) Microbook
BR9606119A (en) Heliceboy
BR7601548U (en) Outletmax
BR7601509U (en) Gafa
BR7601508U (en) Cogafa
BR7601419U (en) Mourao
BR7600429U (en) Hidrolax

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]